CAC
KRTX

Cowen and Company’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cowen and Company’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,999
Closed -$3.48M – 725
2023
Q4 		$3.48M Buy
+10,999
New +$3.48M 0.23% 76